ChoA Pharmaceutical Co., LTD. Q3 operating loss of KRW 0.3 billion on revenue of KRW 13.8 billion
AI summary · Not investment advice
Joa Pharm sold KRW 13.8 billion in Q3 but lost KRW 0.3 billion from its main business; sales fell 10.7% from a year earlier and 9.0% from the prior quarter.
Operating profit · 3 months
KRW -251.2 million
Key facts
- Revenue (3 months)
- KRW 13.8 billion
- Net income (3 months)
- KRW -472.5 million
- Period
- Q3 (cumulative 2026.01.01 ~ 2026.09.30)
- Revenue (prior-year 3 months)
- KRW 15.5 billion
- Revenue (year to date)
- KRW 43.7 billion
- Operating profit (prior-year 3 months)
- KRW -1.5 billion
- Operating profit (year to date)
- KRW -1.4 billion
- Net income (prior-year 3 months)
- KRW -414.6 million
- Net income (year to date)
- KRW -245.9 million
Commentary
AI commentary · Not investment advice
What happened
Choa Pharmaceutical reported its consolidated results for the 3rd quarter of 2026. Sales for the 3 months were KRW 13.82 billion. That is 10.7% lower than the same 3 months a year earlier (KRW 15.48 billion) and 9.0% lower than the previous quarter.
In the company's terms
Operating profit (profit from the core business) for the 3 months was a loss of KRW 251.2 million. A year earlier, the same period showed a loss of KRW 1.49 billion. Net income (final profit after taxes and all other costs) was a loss of KRW 472.5 million, a swing to a loss from the previous quarter. A year earlier, the net loss was KRW 414.6 million.
What changes for shareholders
For the year to date (January 1 to September 30), sales were KRW 43.69 billion. Operating profit was a loss of KRW 1.39 billion. Net income was a loss of KRW 245.9 million.
Comments
No comments yet
Comments from shareholders will appear here.
Ad
Verify your holdings and catch the next disclosure
Verify the stocks you hold and get new disclosures as app alerts.

App design sample
Get the next disclosure as an app alert
Get app alerts for new disclosures and stake changes on your watchlist
C